Centre Hospitalier Universitaire De Besancon

This study tests whether adding a cancer vaccine (UCPVax) to standard treatment (atezolizumab and bevacizumab) can shrink tumors better than standard treatment alone in people with advanced liver cancer that cannot be removed by surgery. About 105 adults who have not had prior sy…

This study tests a new drug, MP0317, combined with standard chemotherapy and immunotherapy for people with advanced bile duct cancer that cannot be removed by surgery. The goal is to see if this combination helps keep the cancer from growing for at least 12 months. About 75 adult…

This study is testing a blood test to quickly identify people who may have colorectal cancer. It includes 400 adults who either had a positive stool test or were already diagnosed with colorectal cancer. The goal is to see if the blood test can help prioritize who needs urgent ca…

This study tests whether a supervised exercise program can improve sleep quality in people with alcohol use disorder. Researchers will recruit 40 adults who have trouble sleeping and drink heavily. Participants will take part in physical activity sessions and track their sleep us…

This study aims to find blood-based biomarkers that can distinguish malignant pancreatic lesions from benign ones. Researchers will analyze blood samples from 100 adults with benign pancreatic conditions and compare them to existing data from patients with pancreatic cancer. The …

This study looks at whether it's possible to measure sleep in regular video game players compared to non-players. Researchers will track sleep using wrist monitors, diaries, and urine tests in 40 adults aged 18 to 40. The goal is to find out what works best for a larger future st…

This study aims to identify biological markers (biomarkers) that can predict outcomes in people with advanced liver cancer treated with the immunotherapy drugs tremelimumab and durvalumab. Researchers will follow 120 participants who have not had prior systemic treatment and are …